News

European Hypertension Guidelines Fill US Void

Author and Disclosure Information

 

EXPERT ANALYSIS FROM THE ESC CONGRESS 2013

Dr. Smith and Dr. Williams said that they had no relevant disclosures. Dr. Mancia said that he has been a consultant to 14 drug and device companies. Dr. Renata Cífková said that she had been a consultant to Daiichi Sankyo, Teva, Zentiva, Merck Sharpe and Dohme, Actavis, Berlin Chemie, Boehringer Ingelheim, and Bayer. Dr. Marx said that he has been a consultant to 13 drug and device companies. Dr. Williams said that he has been a consultant to Pfizer, Merck, Sanofi-BMS, and Novartis.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Diabetes, pro-BNP a bad mix for cardiac health
Clinician Reviews
Diabetic Patients' Stroke Risk Post MI has Plummeted
Clinician Reviews
Just over a third of hypertensive kidney patients are at target BP
Clinician Reviews
Type 2 diabetes encompasses three distinct subtypes
Clinician Reviews
Gestational Diabetes Linked to Sleep Apnea
Clinician Reviews
Think Exercise First for Secondary Prevention?
Clinician Reviews
USPSTF: No Evidence for Routine Blood Pressure Screening in Children
Clinician Reviews
Diabetics Face Increased Treatment-resistant Hypertension Risk
Clinician Reviews
Be Assertive When Tackling Smoking, Obesity, Etc
Clinician Reviews
Drug Combo in New-onset Diabetes
Clinician Reviews